BioMark Diagnostics Inc
CNSX:BUX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
BioMark Diagnostics Inc
CNSX:BUX
|
CA |
|
Cantor Equity Partners Inc
NASDAQ:CEP
|
US |
|
H
|
Health-Chem Corp
OTC:HCLC
|
US |
|
A
|
Asia Standard International Group Ltd
OTC:ASASF
|
HK |
|
L
|
Lamar Advertising Co
DUS:6LA
|
US |
|
V
|
VICI Properties Inc
XMUN:1KN
|
US |
|
Migom Global Corp
OTC:MGOM
|
US |
|
A
|
Arcontech Group PLC
LSE:ARC
|
UK |
|
Tompkins Financial Corp
F:8J0
|
US |
|
D
|
Delfi Ltd
SGX:P34
|
SG |
|
L
|
Lagardere SA
XMUN:LAG
|
FR |
|
Stack Capital Group Inc
TSX:STCK
|
CA |
|
Saturn Metals Ltd
ASX:STN
|
AU |
|
Schweizerische Nationalbank
SIX:SNBN
|
CH |
|
B
|
Banco Bradesco SA
SWB:BREC
|
BR |
|
Propanc Biopharma Inc
OTC:PPCB
|
AU |
Shareholder Yield
Current shareholder yield for BUX is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
BUX Price
BioMark Diagnostics Inc
| Average Annual Return | 6.38% |
| Standard Deviation of Annual Returns | 32.97% |
| Max Drawdown | -43% |
| Market Capitalization | 51.5m CAD |
| Shares Outstanding | 106 480 000 |
| Percentage of Shares Shorted | 0.05% |
